|
|
Proveedores de
Sitagliptin
|
Identificación | CAS |
486460-32-6 | Formula |
C16H15F6N5O |
|
|
22 Proveedores registrados
Más detalles se encuentran aquí
Molecular Formula: C16H15F6N5O Molecular Weight: 407.32
Más detalles se encuentran aquí
Más detalles se encuentran aquí
Description: Sitagliptin (MK 0431) is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts. Sitagliptin is used as a hypoglycemic agent to treat type 2 diabetes. - Molecular Weight:407.31
- Boiling Point:529.9±60.0°C (Predicted)
- Melting Point:14.1-115.7°C
- Purity:>98%
Molecular Formula: C16H15N5OF6 Canonical SMILES: C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N InChI: InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1 InChIKey: MFFMDFFZMYYVKS-SECBINFHSA-N Solubility: Soluble in DMSO Appearance: White to Off-white Solid Application: the treatment of type 2 diabetes Storage: Store at -20°C Synonyms: 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine; MK0431; Xelevia; Januvia; Tesavel; NSC813215; (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1-butanone; 1,2,4-triazolo[4,3-a]pyrazine-7(8H)-propanamine, 5,6-dihydro-γ-oxo-3-(trifluoromethyl)-α-[(2,4,5-trifluorophenyl)methyl]-, (αR)- Más detalles se encuentran aquí
MF: C16H15F6N5O MW: 407,32
Más detalles se encuentran aquí
|
|
|
Proveedores privilegiados
Última actualización 2024-06-09 |